跳至主要内容
临床试验/CTRI/2025/05/087941
CTRI/2025/05/087941尚未招募2/3 期

An open labelled non-randomized clinical study to evaluate the effect of Matra Basti with Sapta Prastha Mahamashadi Tailam and Vishwadya Guggulu (oral) in the management of Kampavata w.s.r. to Parkinson’s disease

Dr.Smeetha Havaragi1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年6月8日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Improvement in symptoms and Quality of living

研究概览

简要总结

Title of study is An open labelled non-randomized clinical study to evaluate the effect of Matra Basti with Sapta Prastha Mahamashadi Tailam and Vishwadya Guggulu oral in the management of Kampavata wsr to Parkinsons disease

1 Vishwady guggulu 500mg tab BD  is given oral route after food  for 90 days

2.Matrabasti with Sapta prasatha Mahamashadi tailam is given for first  7 days for 3 months immediately after food in the Morning

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 65.00 Year(s)(—)

入选标准

  • 1 Patient who are having signs and symptoms of Kampavata (Parkinson s Disease) 2 Patients of both Gender aged between 30 to 65 years irrespective of work and socioeconomic status 3 Patients indicated for Basti Karma 4Patients willing to give informed consent for the study.

排除标准

  • 1 Below 30 years and Above 65 years 2 Pregnant and Lactating Mothers 3 Patient having severe heart disease malignancy uncontrolled Diabetes mellitus and Hypertension 4 Patient associated with major Neurological problems like Spinal cord injury Multiple system atrophy CVA (hemorrhage and infarct) Alzheimer s disease 5 Patient contraindicated for Basti karma 6 Patient not willing to give informed consent for the study.

结局指标

主要结局

Improvement in symptoms and Quality of living

时间窗: 90 days

次要结局

  • Improvement in symptoms and Quality of living(90 days)

研究者

发起方
Dr.Smeetha Havaragi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Smeetha Havaragi

Dr.BRKR Govt Ayurveda Medical college

研究点 (1)

Loading locations...

相似试验